The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease
- Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?
Kamyar Kalantar-Zade, MD
